Immunoblot analysis of CD34 expression in histologically diverse neoplasmsY Natkunam
Department of Pathology, Stanford University Medical Center, Stanford, California 94305, USA
Am J Pathol 156:21-7. 2000
..These results show that the observed immunohistological reactivity with anti-CD34 antibodies is due to the expression of the CD34 protein and not to shared epitopes on unrelated proteins...
Co-expression of CD56 and CD30 in lymphomas with primary presentation in the skin: clinicopathologic, immunohistochemical and molecular analyses of seven casesY Natkunam
Department of Pathology, Stanford University Medical Center, CA 94305, USA
J Cutan Pathol 27:392-9. 2000
..Lymphomas with co-expression of CD56 and CD30 are extremely rare and the significance of this co-expression is unknown...
- Natural killer cell precursor acute lymphoma/leukemia presenting in an infant
Y Natkunam
Department of Pathology, Stanford University Medical Center, Calif 94305, USA
Arch Pathol Lab Med 125:413-8. 2001
..This case emphasizes the need for a strong index of suspicion to recognize this rare entity and to distinguish it from solid tumors and other hematolymphoid neoplasms that occur in infancy...
- Angiocentric lymphomas (lymphomatous vasculitis)
Y Natkunam
Department of Pathology, Stanford University Medical Center, CA 94305, USA
Semin Diagn Pathol 18:67-77. 2001
..The salient clinicopathologic features of natural killer and natural killer-like T-cell lymphomas together with the inherent difficulty of their identification and an integrated approach to their diagnosis are outlined in this article...
- Analysis of MUM1/IRF4 protein expression using tissue microarrays and immunohistochemistry
Y Natkunam
Department of Pathology, Stanford University Medical Center, Stanford, California 94305, USA
Mod Pathol 14:686-94. 2001
....
- Natural killer/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: an increasingly recognized entity with an aggressive course
S Mraz-Gernhard
Departments of Dermatology, Pathology, and Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
J Clin Oncol 19:2179-88. 2001
..To describe and identify the clinical and pathologic features of prognostic significance for natural killer (NK) and NK-like T-cell (NK/T-cell) lymphoma presenting in the skin...
- A unique AML1 (CBF2A) rearrangement, t(1;21)(p32;q22), observed in a patient with acute myelomonocytic leukemia
A M Cherry
Department of Pathology, Stanford University Medical Center, Stanford, CA 94305, USA
Cancer Genet Cytogenet 129:155-60. 2001
..Here, we describe a patient with AML-M4 and a previously unreported rearrangement involving the AML1 locus and an unknown locus on the short arm of chromosome 1 at 1p32...
- Durable remission in recurrent T-cell-rich B-cell lymphoma with the anti-CD20 antibody rituximab
Y Natkunam
Department of Pathology, Stanford University Medical Center, Stanford, CA 94305, USA
Clin Lymphoma 2:185-7. 2001
..We present an unusual case of a 30-year-old man with recurrent TCRBCL arising from lymphocyte-predominant Hodgkin's disease with remarkable response to treatment with the anti-CD20 antibody, rituximab...
- Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma
I S Lossos
Department of Medicine, Division of Oncology, Stanford University Medical Center, CA 94305-5151, USA
Blood 98:945-51. 2001
..High BCL-6 mRNA expression should be considered a new favorable prognostic factor in DLBCL and should be used in the stratification and the design of risk-adjusted therapies for patients with DLBCL. (Blood. 2001;98:945-951)..
